---
title: "Telix Pharmaceuticals reports Q2 results; updates FY2026 outlook"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293286576.md"
description: "Telix Pharmaceuticals reports Q2 results; updates FY2026 outlook"
datetime: "2026-07-21T04:30:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293286576.md)
  - [en](https://longbridge.com/en/news/293286576.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293286576.md)
---

# Telix Pharmaceuticals reports Q2 results; updates FY2026 outlook


### Related Stocks

- [TLX.AU](https://longbridge.com/en/quote/TLX.AU.md)
- [TLX.US](https://longbridge.com/en/quote/TLX.US.md)

## Related News & Research

- [3 Australian Growth Stocks With High Insider Ownership Worth A Closer Look](https://longbridge.com/en/news/293623467.md)
- [Telix appoints three new non-executive directors to expanded board](https://longbridge.com/en/news/293260571.md)
- [Rhythm Pharmaceuticals (RYTM) Faces A Big Undervaluation Call, Is The Upside Already Priced In?](https://longbridge.com/en/news/293893019.md)
- [Corvus Pharmaceuticals (CRVS) to Post Quarterly Earnings on Thursday](https://longbridge.com/en/news/294346824.md)
- [First Trust Advisors LP Sells 2,586 Shares of Madrigal Pharmaceuticals, Inc. $MDGL](https://longbridge.com/en/news/294471972.md)